The prevalence of localised scleroderma in childhood assessed in the administrative claims data from the United States
- PMID: 35382148
- PMCID: PMC8922586
- DOI: 10.1177/2397198318798588
The prevalence of localised scleroderma in childhood assessed in the administrative claims data from the United States
Abstract
Juvenile localised scleroderma is believed an orphan autoimmune disease, which occurs 10 times more often than systemic sclerosis in childhood and is believed to have a prevalence of 1 per 100,000 children. To gain data regarding the prevalence of juvenile localised scleroderma, we assessed the administrative claims data in the United States using the International Classification of Diseases, Ninth Revision diagnosis codes. We found an estimated prevalence in each year ranging from 3.2 to 3.6 per 10,000 children. This estimate is significantly higher as found in previous studies.
Keywords: Localised scleroderma; prevalence.
© The Author(s) 2018.
Conflict of interest statement
Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.
References
-
- Laxer RM, Zulian F. Localized scleroderma. Curr Opin Rheumatol 2006; 18(6): 606–613. - PubMed
-
- Zulian F, Vallongo C, Woo P, et al. Localized scleroderma in childhood is not just a skin disease. Arthritis Rheum 2005; 52(9): 2873–2881. - PubMed
-
- Peterson LS, Nelson AM, Su WP, et al. The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993. J Rheumatol 1997; 24(1): 73–80. - PubMed
-
- Herrick AL, Ennis H, Bhushan M, et al. Incidence of childhood linear scleroderma and systemic sclerosis in the UK and Ireland. Arthritis Care Res (Hoboken) 2010; 62(2): 213–218. - PubMed
LinkOut - more resources
Full Text Sources